United States HR 1843: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Status: Introduced in House (as of 2025-03-05)

State: United States · Session: 119 · Bill: HR 1843

Sponsors: Neal P. Dunn, Kevin Mullin

View United States HR 1843 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.